The novel BTK inhibitor CC-292 exerts antitumor activity, inhibits proliferation, activation and migration of tumor cells, and overcomes stroma-mediated chemoresistance to bendamustine in CLL
LEUKEMIA & LYMPHOMA（2017）
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要